Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
35,924,634
-
Share change
-
+823,008
-
Total reported value
-
$226,542,479
-
Put/Call ratio
-
43%
-
Price per share
-
$6.31
-
Number of holders
-
57
-
Value change
-
+$5,200,153
-
Number of buys
-
30
-
Number of sells
-
26
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q2 2020
As of 30 Jun 2020,
Aptose Biosciences Inc. - Common Shares was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,924,634 shares.
The largest 10 holders included
Consonance Capital Management LP, Nantahala Capital Management, LLC, DRW Securities, LLC, Opaleye Management Inc., PICTET ASSET MANAGEMENT LTD, Corriente Advisors, LLC, Polar Capital LLP, ORBIMED ADVISORS LLC, Prosight Management, LP, and Logos Global Management LP.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.